Detalhe da pesquisa
1.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med
; 390(6): 497-509, 2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324483
2.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
N Engl J Med
; 385(17): 1547-1558, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670042
3.
Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction-associated steatotic liver disease?
Liver Int
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38623714
4.
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
Gut
; 71(9): 1856-1866, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992134
5.
Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals.
BMC Med
; 20(1): 110, 2022 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35351144
6.
Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice.
J Nutr
; 151(6): 1507-1516, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693866
7.
Prebiotic effect on mood in obese patients is determined by the initial gut microbiota composition: A randomized, controlled trial.
Brain Behav Immun
; 94: 289-298, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515740
8.
Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients.
Gut
; 69(11): 1975-1987, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32041744
9.
Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments.
Clin Sci (Lond)
; 134(16): 2117-2135, 2020 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820802
10.
Jaundice with severe leucocytosis.
J Hepatol
; 80(3): e103-e105, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368018
11.
Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions?
Curr Opin Clin Nutr Metab Care
; 22(5): 393-400, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31219825
12.
Fibroscan Reliably Rules Out Advanced Liver Fibrosis and Significant Portal Hypertension in Alcoholic Patients.
J Clin Gastroenterol
; 53(10): 772-778, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30106835
13.
Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues.
J Hepatol
; 78(5): e166-e167, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528235
14.
Alcohol Consumption and Skeletal Muscle: What We Know and What We Would Like to Know.
Calcif Tissue Int
; 113(3): 354-356, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410173
15.
Treatment of severe alcoholic hepatitis: past, present and future.
Eur J Clin Invest
; 47(7): 531-539, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28517024
16.
Regorafenib induced severe toxic hepatitis: characterization and discussion.
Liver Int
; 36(11): 1590-1594, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27500989
17.
Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis.
J Hepatol
; 63(3): 609-21, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25872168
18.
Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome.
Clin Sci (Lond)
; 129(11): 933-49, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26359253
19.
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease.
JHEP Rep
; 6(2): 100963, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38322420
20.
Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance.
JCI Insight
; 9(7)2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587078